成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook
Chinese English Germany Korean

企業(yè)の連絡(luò)先情報(bào)

名前:
電話番號(hào):-
電子メール:sangon@qq.com
國籍:CHINA
ウェブサイト:www.sangon.com
商品の合計(jì)數(shù):47239
214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318

製品カタログ

5-ETHYL-4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDIN-2-YLAMINE, 10 mM in DMSO17899-49-9C8H13N3S
NVP-TAE 684, 10 mM in DMSO5-クロロ-N-[2-メトキシ-4-[4-(4-メチルピペラジノ)ピペリジノ]フェニル]-N′-[2-(イソプロピルスルホニル)フェニル]-2,4-ピリミジンジアミン761439-42-3C30H40ClN7O3S
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate, 10 mM in DMS5-[(2R)-2-アミノプロピル]-1-[3-(ベンゾイルオキシ)プロピル]-2,3-ジヒドロ-1H-インドール-7-カルボニトリル(2R,3R)-2,3-ジヒドロキシブタン二酸ビス239463-85-5C26H31N3O8
Taladegibタラデギブ1258861-20-9C26H24F4N6O
TAK-901934541-31-8C28H32N4O3S
(S)-2-((R)-3-(4-chlorophenyl)-N’-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-methylbutanamide,1404117-65-2C27H27Cl2N5O3S
Tanzisertib, 10 mM in DMSOタンジセルチブ899805-25-5C21H23F3N6O2
TAK-071, 10 mM in DMSO4-フルオロ-2-[(3S,4S)-4-ヒドロキシオキサン-3-イル]-5-メチル-6-{[4-(ピラゾール-1-イル)フェニル]メチル}-3H-イソインドール-1-オン1820812-16-5C24H24FN3O3
Subasumstat, 10 mM in DMSO1858276-04-6C25H28ClN5O5S2
Thalidomide-NH-C2-PEG3-OH2140807-23-2C21H27N3O8
Acetic acid, 2-[4-[(2-ethyl-3-benzofuranyl)carbonyl]phenoxy]-, 10 mM in DMSO91627-33-7C19H16O5
Tarloxotinib bromide, 10 mM in DMSO1636180-98-7C24H24Br2ClN9O3
Takeda103A, 10 mM in DMSO865609-72-9C24H23F2N7O
8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylic acid816450-73-4C19H21N3O2
GP130 receptor agonist-1, 10 mM in DMSO339303-87-6C15H11FN2S
TAK-615, 10 mM in DMSO1664335-55-0C25H22FNO4
TAK-020, 10 mM in DMSO1627603-21-7C18H17N5O3
Tafetinib1032265-57-8C24H29FN4O2
gamma-preprotachykinin amide (72-92) acetate
3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile, 10 mM in DMSO2759137-87-4C18H14N4O
(3Z)-1-methyl-3-[2-(4-methylphenyl)-2-oxo-ethylidene]piperazin-2-one, 10 mM in DMSO178408-16-7C14H16N2O2
(D-Trp12,Tyr34)-pTH (7-34) amide (bovine) acetate
5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole, 10 mM in DMSO2863687-18-5
TA-03, 10 mM in DMSO5778-80-3C14H16N2O
NVP-TAE 226, 10 mM in DMSOTAE-226761437-28-9C23H25ClN6O3
Targocil, 10 mM in DMSOタルゴシル1200443-21-5C21H22ClN5O4S
TAK-243, 10 mM in DMSO1450833-55-2C19H20F3N5O5S2
5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione26166-92-7C13H9BrN2O4
LY34051052326428-25-3C26H39N7O3
GPR34 receptor antagonist 2, 10 mM in DMSO907952-06-1C31H26ClNO4
TAK-6531358751-06-0C19H23N3O3S
MAT2A inhibitor 4, 10 mM in DMSO1391934-91-0C16H15ClFN
5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid, 10 mM in DMSO452105-33-8C16H13FN2O3
TAK-733, 10 mM in DMSO3-[(R)-2,3-ジヒドロキシプロピル]-6-フルオロ-5-[(2-フルオロ-4-ヨードフェニル)アミノ]-8-メチルピリド[2,3-d]ピリミジン-4,7(3H,8H)-ジオン1035555-63-5C17H15F2IN4O4
4-[(E)-{[4,6-Di(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazono}methy l]-2,6-dimethoxyphenol, 10 mM in DMSO321557-16-8C20H27N7O5
5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-, rel-, 10 mM in DMSO1194954-52-3C19H23N9O
Taltirelin acetate, 10 mM in DMSO1549593-23-8C19H27N7O7
Talabostat mesylate, 10 mM in DMSOタラボスタットメシラート150080-09-4C10H23BN2O6S
Fasiglifam, 10 mM in DMSOファシグリファム1000413-72-8C29H32O7S
4-(6,7-dimethoxyquinolin-4-yl)oxyaniline, 10 mM in DMSO4-[(6,7-ジメトキシキノリン-4-イル)オキシ]アニリン190728-25-7C17H16N2O3
TAK-593, 10 mM in DMSON-[5-({2-シクロプロパネアミドイミダゾ[1,2-b]ピリダジン-6-イル}オキシ)-2-メチルフェニル]-1,3-ジメチル-1H-ピラゾール-5-カルボキサミド1005780-62-0C23H23N7O3
TAK-632, 10 mM in DMSON-[2-フルオロ-5-[[2-(シクロプロピルカルボニルアミノ)-7-シアノベンゾチアゾール-6-イル]オキシ]フェニル]-3-(トリフルオロメチル)ベンゼンアセトアミド1228591-30-7C27H18F4N4O3S
Tanimilast1239278-59-1C30H30Cl2F2N2O8S
TA-01, 10 mM in DMSO1784751-18-3C20H12F3N3
Taminadenant, 10 mM in DMSO5-ブロモ-2,6-ジ(1H-ピラゾール-1-イル)ピリミジン-4-アミン1337962-47-6C10H8BrN7
4-QUinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo-, 10 mM in DMSO939760-13-1C25H22N4O5S
TAS0728, 10 mM in DMSO4-アミノ-N-{4-[(ジメチルカルバモイル)メチル]-2,3-ジメチルフェニル}-1-[(3R)-1-(プロパ-2-エノイル)ピペリジン-3-イル]ピラゾロ[3,4-d]ピリミジン-3-カルボキサミド2088323-16-2C26H32N8O3
C/EBPα inducer 12374285-52-4C20H12FN3O4
SCR130, 10 mM in DMSO2377858-38-1C19H13Cl2N3O2S
AG-270, 10 mM in DMSO2201056-66-6C30H27N5O2
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-, 10 mM in DMSO80305-11-9C20H25FN2O3
Pomalidomide-PEG3-OH2140807-36-7C19H23N3O7
2-(2,6-dioxopiperidin-3-yl)-4-((9-hydroxynonyl)oxy)isoindoline-1,3-dione2619511-72-5C22H28N2O6
Talampanel, 10 mM in DMSOタランパネル161832-65-1C19H19N3O3
(1S,4R)-N-Desmethyl Sertraline Hydrochloride, 10 mM in DMSO675126-07-5C16H16Cl3N
Fosravuconazole L-lysine ethanolateホスラブコナゾール　L－リシンエタノール付加物914361-45-8C31H40F2N7O8PS
TAK-960, 10 mM in DMSO4-({9-シクロペンチル-7,7-ジフルオロ-5-メチル-6-オキソ-5H,6H,7H,8H,9H-ピリミド[4,5-b][1,4]ジアゼピン-2-イル}アミノ)-2-フルオロ-5-メトキシ-N-(1-メチルピペリジン-4-イル)ベンズアミド1137868-52-0C27H34F3N7O3
Takeda-6d, 10 mM in DMSO1125632-93-0C27H19ClFN5O3S
Targapremir-210ターガプレミル2101049722-30-6C32H36N10O2
Balipodect, 10 mM in DMSOバリポデクト1238697-26-1C23H17FN6O2
TAI-1, 10 mM in DMSO1334921-03-7C24H21N3O3S
Dazonone, 10 mM in DMSO105622-85-3C11H10ClN3O
TAK-659 hydrochloride1952251-28-3C17H22ClFN6O
TAK-715, 10 mM in DMSON-[4-[2-エチル-4-(3-メチルフェニル)チアゾール-5-イル]-2-ピリジル]ベンズアミド303162-79-0C24H21N3OS
TAK-418, 10 mM in DMSO1818252-53-7
NSC 73150, 10 mM in DMSO66680-03-3C12H12N4O2
Talnetant, 10 mM in DMSOSB-223412174636-32-9C25H22N2O2
TAK-779, 10 mM in DMSO229005-80-5C33H39N2O2.Cl
N,N,O-Tridesmethylvenlafaxine, 10 mM in DMSO149289-29-2C14H21NO2
TAK-285, 10 mM in DMSON-[2-[4-[[3-クロロ-4-[3-(トリフルオロメチル)フェノキシ]フェニル]アミノ]-5H-ピロロ[3,2-d]ピリミジン-5-イル]エチル]-3-ヒドロキシ-3-メチルブタンアミド871026-44-7C26H25ClF3N5O3
Taprenepag, 10 mM in DMSOタプレネパグ752187-80-7C24H22N4O5S
TAK-441TAK-4411186231-83-3C28H31F3N4O6
T-900607, 10 mM in DMSO261944-52-9C14H10F5N3O4S
TAO Kinase inhibitor 1, 10 mM in DMSO850467-66-2C25H24N2O2
TAK-041, 10 mM in DMSO1929519-13-0C18H15F3N4O3
TAM-IN-22135642-56-5C31H27F2N7O3
Exo-1, 10 mM in DMSO461681-88-9C15H12FNO3
Thalidomide-PEG4-Propargyl2098799-77-8C24H28N2O9
Benzonitrile, 3,3''-[(2-oxo-1,3-cyclohexanediylidene)dimethylidyne]bis- (9CI), 10 mM in DMSO63476-70-0C22H16N2O
EAAT2 activator 1, 10 mM in DMSO892415-28-0C16H11ClFN3S
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide, 10 mM in DMSO2505001-62-5C16H19Cl2N3O4S
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate, 10 mM in DMSOメタンスルホン酸2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチル160969-03-9C11H13F3O5S
KCNQ2/3 activator-1, 10 mM in DMSO1009344-33-5C23H29FN2O
TA-02, 10 mM in DMSO1784751-19-4C20H13F2N3
Takinib, 10 mM in DMSOタキニブ1111556-37-6C18H18N4O2
1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID, 10 mM in DMSO260555-42-8C13H13NO5
Pomalidomide-PEG2-OH2143097-10-1C17H19N3O6
Thalidomide-NH-PEG1-NH2 hydrochloride2154342-56-8C17H21ClN4O5
2H-Imidazo[4,5-b]pyrazin-2-one, 1,3-dihydro-6-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(tetrahydro-2H-pyran-4-yl)methyl]-, 10 mM1021917-65-6C19H23N5O3
Cyclopenta[c][1]benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aR,4S,9bS)-rel-, 10 mM in DMSO533883-77-1C18H18O3
3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide, 10 mM in DMSO246238-55-1C28H24ClN3O6
TAE-11414469-59-2C39H51I3N6O9
Taprizosin210538-44-6C25H26N6O4S
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione2093536-10-6C20H24N2O6
Tabernanthalog, 10 mM in DMSO2483829-58-7C14H18N2O
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)pyrazine-2-carboxamide, 10 mM in DMSO312508-42-2C14H12N4OS
N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline, 10 mM in DMSO1352608-94-6C22H18BrN7
ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate, 10 mM in DMSO2738381-94-5C22H18N4O3
GR103545, 10 mM in DMSO126766-43-6C23H29Cl2N3O7
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine1071135-06-2C23H28N6
214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318
Copyright 2017 ? ChemicalBook. All rights reserved